Thermo Fisher ScientificvsZevra Therapeutics

TMO and ZVRA stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$688.75

Value $256B

-0.58%
TMO's page

ZVRA

Zevra Therapeutics, Inc.

$9.07

Value $533M

-2.26%
ZVRA's page

Thermo Fisher Scientific (TMO) has a market value of $256B and Zevra Therapeutics (ZVRA) $533M. Over the last year, with dividends, TMO moved +20.0% and ZVRA -6.5%. The P/E is 36.2 for TMO and 7.0 for ZVRA. Dividend yield: TMO 0.27%, ZVRA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMO$256B

    ZVRA$533M

    TMO is 480 times ZVRA

  • Revenue, 12 months

    TMO$47.4B

    ZVRA$148M

    TMO is 320 times ZVRA

  • Net income, 12 months

    TMO$7.1B

    ZVRA$78M

    TMO is 91 times ZVRA

  • Operating margin

    TMO17.9%

    ZVRA60.8%

    42.9 points apart

  • ROIC

    TMO8.2%

    ZVRA36.3%

    28.1 points apart

  • P/E

    TMO36.2

    ZVRA7.0

    TMO is 5.2 times ZVRA

  • Dividend yield

    TMO0.3%

    ZVRA0.0%

    0.3 points apart

  • 5-year return

    TMO+9.6%

    ZVRA+9.4%

    0.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMO+9.6%

ZVRA+9.4%

5010015020222023202420252026
Returns by period
PeriodTMOWith dividendsZVRAWith dividends
1 year since November 18, 2025+20.0%Price +19.6%-6.5%Price -6.5%
3 years since November 17, 2023+49.1%+14.2% a yearPrice +47.7%+109.0%+27.9% a yearPrice +109.0%
5 years since November 18, 2021+9.6%+1.8% a yearPrice +8.0%+9.4%+1.8% a yearPrice +9.4%
10 years since November 21, 2016+384.7%+17.1% a yearPrice +371.2%-86.2%-18.0% a yearPrice -86.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMOThermo Fisher ScientificZVRAZevra Therapeutics

Valuation

TMOZVRA
Valuation
Price$688.75$9.07
Market value$256B$533M
Enterprise value (EV)$291B$337M
P/E36.27.0
P/E, 5-year median32.7–
P/B4.72.2
EV/EBIT34.43.8
Free cash flow yield3.0%7.2%

Results and growth

TMOZVRA
Results and growth
Revenue, 12 months$47.4B$148M
Net income, 12 months$7.1B$78M
Free cash flow, 12 months$7.6B$38M
Earnings per share, 12 months$18.96$1.19
Revenue growth, year on year3.9%350.9%
Revenue growth a year, past+6.7%over 5 years+51.6%over 5 years
EPS growth a year, past+2.1%over 5 years–

Margins and returns on capital

TMOZVRA
Margins and returns on capital
Gross margin–95.4%
Operating margin17.9%60.8%
Net margin14.9%52.8%
ROIC8.2%36.3%
ROE13.4%41.1%

Balance sheet

TMOZVRA
Balance sheet
Cash$6.1B$196M
Total debt$41.4B$1.2M
Net debt / EBITDA3.7-2.1
Interest cover5.5×24.6×

Dividends and buybacks

TMOZVRA
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$1.84–
Dividend growth a year, past+14.3%over 5 years–
Buyback yield1.2%–
Shareholder yield1.4%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMO or ZVRA

Didn't find what you were looking for?

Ask us
Which is bigger, Thermo Fisher Scientific or Zevra Therapeutics?

By market value, Thermo Fisher Scientific ($256B) is about 480.5 times Zevra Therapeutics ($533M), at today's prices.

How did TMO and ZVRA stock do over the last 10 years?

Since November 21, 2016, TMO's price moved +371.2% and ZVRA's -86.2%. With dividends: TMO +384.7% (+17.1% a year), ZVRA -86.2% (-18.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMO or ZVRA?

The dividend yield at today's price is 0.27% for Thermo Fisher Scientific and none for Zevra Therapeutics. Over the last twelve months they paid $1.84 and – per share.

What is the P/E of TMO and ZVRA?

At today's price, the P/E is 36.2 for TMO and 7.0 for ZVRA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Thermo Fisher Scientific or Zevra Therapeutics?

Over the last twelve months, the net margin was 14.9% for Thermo Fisher Scientific and 52.8% for Zevra Therapeutics, and the operating margin 17.9% and 60.8%. Revenue was $47.4B and $148M.

Which is the better investment, Thermo Fisher Scientific or Zevra Therapeutics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.